Reference
Snowsill T, et al. Model-Based Cost-Utility Analysis of Erythropoiesis-Stimulating Agents for the Treatment of Cancer-Treatment Induced Anaemia in the UK NHS. 17th Annual European Conference of the International Society for Pharmacoeconomics and Outcomes : (plus poster) abstr. PCN157, 8 Nov 2014. Available from: URL: http://www.ispor.org/RESEARCH_STUDY_DIGEST/list.asp?qs=39613.
Rights and permissions
About this article
Cite this article
Cost effectiveness of ESAs highly uncertain. PharmacoEcon Outcomes News 717, 18 (2014). https://doi.org/10.1007/s40274-014-1743-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1743-9